Penicillin-binding proteins (PBPs) catalyze the final stages of bacterial cell wall biosynthesis. PBPs form stable covalent complexes with ␤-lactam antibiotics, leading to PBP inactivation and ultimately cell death. To understand more clearly how PBPs recognize ␤-lactam antibiotics, it is important to know their energies of interaction. Because ␤-lactam antibiotics bind covalently to PBPs, these energies are difficult to measure through binding equilibria. However, the noncovalent interaction energies between ␤-lactam antibiotics and a PBP can be determined through reversible denaturation of enzyme-antibiotic complexes. Escherichia coli PBP 5, a D-alanine carboxypeptidase, was reversibly denatured by temperature in an apparently two-state manner with a temperature of melting (T m ) of 48.5°C and a van't Hoff enthalpy of unfolding (⌬H VH ) of 193 kcal/mole. The binding of the ␤-lactam antibiotics cefoxitin, cloxacillin, moxalactam, and imipenem all stabilized the enzyme significantly, with ⌬T m values as high as +4.6°C (a noncovalent interaction energy of +2.7 kcal/mole). Interestingly, the noncovalent interaction energies of these ligands did not correlate with their second-order acylation rate constants (k 2 /KЈ). These rate constants indicate the potency of a covalent inhibitor, but they appear to have little to do with interactions within covalent complexes, which is the state of the enzyme often used for structure-based inhibitor design.
Penicillin-binding proteins (PBPs) are involved in the biosynthesis of bacterial cell wall peptidoglycan. All bacteria analyzed to date have multiple PBPs, which function to crosslink the cell wall peptides (transpeptidation) and to remove the C terminal D-alanine residue from cell wall peptides (carboxypeptidation). PBPs are the targets of ␤-lactam antibiotics, which react with these enzymes to form stable covalent complexes, leading to inactivation of the PBP and ultimately to cell death (Tipper and Strominger 1965; Wise and Park 1965; Ghuysen and Dive 1994) . A broad range of ␤-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems, are used clinically, and seemingly subtle structural differences have dramatic effects on their biological activity (Neuhaus and Georgopapadakou 1992) .
Despite much interest in understanding the molecular interactions of ␤-lactams with PBPs, their interaction energies have been difficult to determine. The noncovalent first encounter complex between the antibiotic and enzyme proceeds quickly to an acyl-enzyme adduct by attack of the catalytic serine hydroxyl on the carbonyl carbon of the ␤-lactam ring (Fig. 1) . Because of this covalent bond formation and the resultant ␤-lactam ring opening, ␤-lactam antibiotics essentially bind irreversibly to PBPs, and there is no equilibrium between the free and covalently bound ligand. Hence, a thermodynamic interaction energy (⌬G interaction ) cannot be determined for the covalent complex.
Previously, differential protein stability has been used to measure the thermodynamic complementarity of both ␤-lactam and non-␤-lactam ligands for ␤-lactamase enzymes (Rahil and Pratt 1994; Beadle et al. 1999) , which are structurally and functionally related to PBPs (Kelly et al. 1986; Massova and Mobashery 1998; Fonze et al. 1999; Davies et al. 2001) . Rather than measuring the equilibrium constant between bound and free ligand, this technique measures the equilibrium constant between folded and unfolded protein (Schellman 1976) , in the presence and absence of a ligand. The free enzyme and the enzyme in complex with a covalent ligand are reversibly denatured by temperature; each denaturation is described by a temperature of melting (T m ), a van't Hoff enthalpy of denaturation (⌬H VH ), and an entropy of denaturation (⌬S u ). Because thermal denaturation does not break covalent bonds, the difference between the unfolding energy of the free enzyme and that of the covalent complex reflects the noncovalent interaction energy between the ligand and the enzyme in the covalent complex (⌬G interaction ). Using a thermodynamic cycle (Fig. 2) , this process can be described by the following equation: ⌬G interaction + ⌬G covalent + ⌬G u1 − ⌬G 3 − ⌬G covalent − ⌬G u2 ‫ס‬ 0. If we assume that the noncovalent interactions between the ligand and the denatured state are negligible (i.e., ⌬G 3 ‫ס‬ 0) and that the covalent energies between the enzyme and the ligand (⌬G covalent ) are the same in the folded and unfolded states, then: ⌬G interaction ‫ס‬ ⌬G u2 − ⌬G u1 ‫ס‬ ⌬⌬G u . Thus, the noncovalent interaction energy is equal to the net differential stability between the apo-and ligandbound enzyme. This method closely resembles that used to determine stabilization energies of mutant enzymes, and it is reliable provided that the denaturation of both the apo-and bound enzyme is reversible, can be modeled as two-state, and the noncovalent energy of the denatured state is not significantly affected by the covalently bound ligand.
In this study, we investigated the complementarity of ␤-lactam antibiotics for E. coli PBP 5, a D-alanine carboxypeptidase, by reversible thermal denaturation of free PBP 5 and PBP 5 covalently bound to several ␤-lactam antibiotics. These studies provide the first quantitative measurement of the noncovalent interaction energies of a PBP with covalently bound ␤-lactam antibiotics. Intriguingly, these noncovalent interaction energies do not correlate with the second-order rate constants for formation of the acyl-enzyme complex (k 2 /KЈ), which are considered the best indicators of the inhibitory potency of ␤-lactam antibiotics with PBPs (Frere et al. 1975; Frere et al. 1992; Jamin et al. 1993; Graves-Woodward and Pratt 1998; Lu et al. 1999) .
Results

Denaturation of PBP 5
PBP 5 was reversibly denatured by temperature (Fig. 3) . When monitored by far-UV CD, a measure of secondary structure, PBP 5, has an average T m of 47.9°C and a ⌬H VH of 156 kcal/mole. Following denaturation, the sample was immediately cooled, and 100% of the folded CD signal returned. Moreover, cooling the denatured sample at a rate of 2°C/min, the same rate at which it had been denatured produced a renaturation curve that overlaid almost exactly the denaturation curve (data not shown). These data suggest that renaturation follows the same pathway as denaturation and that the folded and unfolded states are in thermodynamic equilibrium throughout the transition, a requirement for thermodynamic analysis.
To investigate whether PBP 5 exhibited two-state behavior, thermal denaturations and renaturations of PBP 5 were also monitored by fluorescence emission following excitation at 285 nm, a measure of tertiary structure. By fluorescence, PBP 5 has an average T m of 48.5°C and a ⌬H VH of 193 kcal/mole (Fig. 3 ). The T m and ⌬H VH values of PBP 5 when monitored by fluorescence were essentially the same as those when monitored by far-UV CD. These data suggest that the values are independent of spectral technique, consistent with PBP 5 melting in a two-state fashion. 
Denaturation of PBP-␤-lactam adducts
To assess the complementarity of ␤-lactams for PBP 5, covalent complexes were formed by incubation of PBP 5 with each of cefoxitin, cloxacillin, imipenem, or moxalactam. These complexes were then reversibly denatured by temperature, and the T m and ⌬H VH values were determined. Binding of each of these antibiotics increased the stability of PBP 5 ( Fig. 4 ; Table 1 ); cloxacillin and imipenem stabilized PBP 5 to a greater extent than either cefoxitin or moxalactam. We note that the van't Hoff enthalpies of denaturation are often reduced in the ligand complexes. We suspect that this reflects the difficulty in fitting to the fluorescent denaturation curves, which are innately temperature dependent. However, a direct comparison of the free energies was also made by comparing the equilibria of unfolding at a reference temperature using the Gibbs-Helmholtz equation. By picking a temperature within the range of melting temperatures, namely 51.3°C, extrapolation errors are minimized. For these analyses, we used the van't Hoff enthalpies of each curve to determine equilibria. The two methods gave similar values for ⌬⌬G u (Table 1 ). The free energies of stabilization reported are valid near the temperature of melting, but some caution is warranted when extrapolating these values to room temperature.
Determination of second-order rate constants for formation of the acyl-enzyme complex
The second-order rate constant (k 2 /KЈ) is considered the best indicator of inhibitory activity of a ␤-lactam antibiotic against a PBP (Frere et al. 1992 ). The k 2 /KЈ constant of [ (Table 1) .
Discussion
␤-Lactam binding to PBP 5
The ␤-lactam antibiotics cloxacillin, cefoxitin, moxalactam, and imipenem all stabilized the enzyme when covalently complexed with PBP 5. Surprisingly, their noncovalent interaction energies do not correlate with the second-order rate constants (k 2 /KЈ) for these compounds. Based on k 2 /KЈ values, the order of potency of the ␤-lactams for inhibiting PBP 5 is: cefoxitin > imipenem > moxalactam > cloxacillin. Based on ⌬⌬G u values, the order of complementarity of the ␤-lactams for PBP 5 is: cloxacillin Ն imipenem > cefoxitin > moxalactam. Strikingly, cloxacillin, the ␤-lactam that best complements PBP 5 in the acyl state, is the least potent inhibitor of PBP 5. Thus, ␤-lactam antibiotics with greater complementarity to PBP 5 in the acyl-enzyme complex, as shown by more favorable interaction energies, are not better inhibitors of PBP 5.
The discrepancy between the interaction energies and second-order rate constants becomes less troubling when Fig. 2 . A thermodynamic cycle for determining the noncovalent interaction energy (⌬G interaction ) between PBP 5 and a ␤-lactam. This process can be described by the following equation:
If we assume that the noncovalent interactions between the ligand and the denatured state are negligible (i.e., ⌬G 3 ‫ס‬ 0), and that the covalent energies between the enzyme and the ligand (⌬G covalent ) are the same in the folded and unfolded states, then:
one considers that these values are determined for different states of the enzyme and ligand. The second-order acylation rate constant (k 2 /KЈ) measures the fit of the ligand to the active site in the precovalent complex multiplied by the rate of the chemical step. The noncovalent interaction energies measure the complementarity of a ␤-lactam to a PBP in the acylated, postcovalent complex. Because acylated, ringopened ␤-lactam antibiotics bound to PBPs differ significantly from their precovalent, closed-ring forms (Kelly et al. 1989) , and because there is no kinetic component to the noncovalent interaction energies measured by stability, the lack of correlation between the acylation rate constants and noncovalent interaction energies can be understood. An effective ␤-lactam must complement the active site of its target sufficiently to allow rapid acylation, be chemically predisposed to the acylation reaction itself, and then deacylate very slowly. The rate of deacylation can depend on many factors, including steric blockage of hydrolytic attack (Patera et al. 2000) . Once acylated, complementarity within the acyl-enzyme complex may play only a secondary role in determining how effective an inhibitor is. In this light, efforts to improve inhibitors by improving complementarity within covalent complexes may be misguided.
Conclusions
The ability to determine the energetic complementarity of ␤-lactams for PBP 5 provides a method for understanding their interactions in the covalent complex, which is the state often used as a basis for structure-based drug design. The only requirements for such thermodynamic analyses are the reversible denaturation of the enzyme and enzyme-ligand complex and the ability to isolate a stable enzyme-ligand complex. This method may be used to study the binding of a broad variety of covalent ligands and their enzyme targets. However, it is clear that improving the noncovalent complementarity within a covalently bound complex will not necessarily improve the potency of an inhibitor.
Materials and methods
Enzyme preparation
A soluble form of PBP 5 constructed by deletion of the last 17 amino acids from the C terminus was expressed in the cytoplasm of E. coli. PBP 5 was precipitated from the soluble fraction of cell lysates with 50% ammonium sulfate, and the protein was redissolved in 50 mM Tris, 150 mM NaCl, pH 7.5 (Buffer A), and purified by covalent ampicillin affinity chromatography as previously described (Nicholas and Strominger 1988) . The enzyme was dialyzed against Buffer A, concentrated to 6-8 mg/mL, and stored at −80°C. Interaction energies of ␤-lactams with PBP 5 www.proteinscience.org 1257
Sample preparation
PBP 5 was diluted to a concentration of approximately 6 g/mL in 3.5 mL of 50 mM potassium phosphate, 200 mM potassium chloride, 38% (v/v) ethylene glycol, pH 6.8. The buffer was prepared using ACS reagent grade potassium chloride from Sigma Chemical, potassium phosphate from Aldrich Chemical, spectroscopic grade ethylene glycol from Sigma, and doubly deionized water.
To form antibiotic-PBP 5 complexes, PBP 5 was incubated with a 50-to 100-fold molar excess of cloxacillin, moxalactam, cefoxitin (all from Sigma Chemical), or imipenem for periods of 5 min to 45 min. We note that some ␤-lactam antibiotics took a longer incubation time to reach a constant, maximal T m ; we report the largest reproducible ⌬T m observed. An aliquot of the incubation mixture was then added to 3.5 mL of buffer solution, and the denaturation experiments were performed (see below). ⌬⌬G u values were determined by the method of Schellman for all complexes of enzyme with inhibitor (Becktel and Schellman 1987) :
where
Because of the variations observed in the ⌬H VH values of the thermal denaturations, we also compared the ⌬⌬G u values within the transition region directly using the Gibbs-Helmholtz equation:
For each denaturation, the ⌬G value was calculated using its thermodynamic parameters (T m , ⌬H VH, ⌬S) as the reference values (T°, ⌬H°, ⌬S°) with T set to a temperature within the range of the observed T m values, specifically at 51.3°C. ⌬⌬G u values were calculated as the difference between the ⌬G value of each complex and the enzyme alone. Positive ⌬⌬G u values indicate increases in the T m , hence stabilization; negative ⌬⌬G u values indicate decreases in the T m , hence destabilization.
Thermal denaturation as monitored by CD and fluorescence
CD and fluorescence experiments were performed in a Jasco J-715 spectropolarimeter with a fluorescence emission attachment, which allows both spectra to be measured simultaneously. Temperature was controlled with a Jasco PTC-348WI peltier-effect temperature controller, using an in-cell probe to measure temperature. All solutions were stirred with a magnetic stirbar. Quartz cells with a 1-cm path length from Hellma (Jamaica, NY) were used for all experiments. The program EXAM (Kirchhoff 1993) was used to calculate all T m and ⌬H VH values. For these analyses, the change in heat capacity upon denaturation, (⌬C p ) was set to 6.0 kcal/mol·K, consistent with theoretical considerations (Myers et al. 1995) ; neither the T m nor the ⌬H VH values varied appreciably with ⌬C p values. Samples were monitored for helical content by CD in the far-UV region at 223 nm, and for the tertiary structure by fluorescence emission following excitation at 285 nm. Thermal melting was performed at ramp rates of 2°C/min. Reversibility was judged using two criteria: the return of the original CD signal upon quick cooling and retracing of the path of the denaturation curve on slow cooling (at a ramp rate equal to that of unfolding, 2°C/min).
Acylation rate constant determination
Second-order rate constants for acylation (k 2 /KЈ) of PBP 5 by ␤-lactam antibiotics were determined from a time course of formation of the acyl-enzyme complex essentially as described (Frere et al. 1992) , except k 2 /KЈ for [ , followed by addition of PBP 5 (0.25 g; 6.3 pmole), and the mixture was incubated at 30°C for 10 min. The level of radioactivity bound to the proteins was quantitated as described above. k 2 /KЈ constants were calculated using the equation:
where EC o and EC L represent the ([ 125 I]IPV-PBP 5) formed in the absence and presence of the unlabeled antibiotic, respectively, and C U and C L represent the concentrations of the unlabeled and labeled antibiotic, respectively (Frere et al. 1992) .
